The Effectiveness of Retinalamin® Administered by Various Intramuscular Injection Timings in the Treatment of Patients with the Dry Form of Age- Related Macular Degeneration

• Published in: Rossiĭskiĭ oftalʹmologicheskiĭ zhurnal Vol. 9; no. 1; pp. 39 - 46
• Main Authors: V. V. Neroev, O. V. Zaitseva, T. D. Okhotsimskaya, I. V. Tsapenko, E. P. Lantukh
• Format: Journal Article
• Language: Russian
• Published: Real Time Ltd 01.10.2018
• Subjects: age-related macular degeneration; retinalamin; treatment; возрастная макулярная дегенерация; лечение; ретиналамин; цитомедины

The paper presents the evaluation of Retinalamin efficacy administered intramuscularly to 90 patients (180 eyes) aged 47 to 75 (averagely, 65.9 ± 7.18 years) with various stages of dry age-related macular degeneration (AMD) once or twice in 6 months. The data of multifocal electroretinography (MfERG...